|

Detection of Genetic Markers of Lung Cancer

RECRUITINGSponsored by University of Pittsburgh
Actively Recruiting
SponsorUniversity of Pittsburgh
Started1996-06
Est. completion2050-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT00280202

Summary

The purpose of this research study is to determine the genetic changes and immunologic changes that are involved in the development and progression of bronchogenic lung cancer.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Histologic confirmation of lung cancer, lung metastases from a primary site other than lung, mesothelioma or a radiographic lesion highly suspicious for malignancy
* Written informed consent.
* To be scheduled for a biopsy or surgical resection or have already had a biopsy and/or surgical removal of a lung mass

Exclusion Criteria:

None

Conditions2

CancerLung Cancer

Locations1 site

Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232
Julie A Ward, BSN412-647-8583wardj@upmc.edu

Browse More Trials

Cancer trialsLung Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.